IDEXX Laboratories Announces First Quart...(cts of operations outside the U.S. inclu...),Health

Date:4/24/2009

cts of operations outside the U.S., including from currency fluctuations, different regulatory, political and economic conditions, and different market conditions; and the loss of key employees. A further description of these and other factors can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2008, in the section captioned "Risk Factors."

    IDEXX Laboratories, Inc. and Subsidiaries
    Consolidated Statement of Operations
    Amounts in thousands except per share data (Unaudited)

                                                Three Months Ended
                                                March 31, March 31,
                                                    2009      2008
    Revenue:   Revenue                          $236,455  $249,074
    Expenses
    and
    Income:    Cost of revenue                   112,022   119,238
               Gross profit                      124,433   129,836
               Sales and marketing                40,985    44,001
               General and administrative         29,068    29,821
               Research and development           15,939    17,295
               Income from operations             38,441    38,719
               Interest expense, net                 396       485
               Income before provision for
                income taxes                      38,045    38,234
               Provision for income taxes         11,974    10,683
    Net
    Income:    Net income                        $26,071   $27,551
               Earnings per share: Basic           $0.44     $0.45
               Earnings per share: Diluted         $0.43     $0.43
               Shares outstanding: Basic          59,172    60,865
               Shares outstanding: Diluted        60,606    63,558



    IDEXX Laboratories, Inc. and Subsidiaries
    Key Operating Information (Unaudited)

                            
'/>"/>
SOURCE  IDEXX Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
Related medicine news :

1. IDEXX Laboratories to Present at JPMorgan Healthcare Conference
2. IDEXX Laboratories to Release 2007 Fourth Quarter and Full-Year Financial Results
3. IDEXX Laboratories Announces Fourth Quarter Results
4. IDEXX Laboratories Announces Increase in Share Repurchase Program
5. IDEXX Laboratories to Release 2008 First Quarter Financial Results
6. IDEXX Laboratories to Present at William Blair 28th Annual Growth Stock Conference
7. IDEXX Laboratories Names William Brown Corporate Vice President
8. IDEXX Laboratories to Release 2008 Fourth Quarter and Full-Year Financial Results
9. IDEXX Laboratories Announces Fourth Quarter and Full Year Results
10. IDEXX Laboratories to Release 2009 First Quarter Financial Results
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)